Süreç akışı

Nos pacientes em hemodiálise, não houve aumento do VO2max em

nenhum dos grupos. Os parâmetros de rigidez arterial não se alteraram com o treinamento físico. A morfologia cardíaca melhorou em ambos os grupos, assim como a hemoglobina e a creatinina. O que conota que talvez o grupo controle tenha sido influenciado pelo protocolo, uma vez que estavam no mesmo ambiente (sala de hemodiálise) e talvez tenham realizado espontaneamente algum tipo de exercício resistido.

Nos pacientes de tratamento conservador, portanto em fase mais precoce da uremia houve melhor resposta ao treinamento físico. O VO2max

aumentou no grupo tratado, a VOP e a PADc melhoraram no grupo tratado, bem, como a morfologia cardíaca, espessura de carótida e proteína C reativa.

Análise post hoc realizada para verificar se a eventual melhora de parâmetros cardiovasculares pudesse estar condicionado à melhora da capacidade aeróbica, evidenciou uma melhora discreta na morfologia cardíaca dos pacientes que melhoraram a VO2max.

Considerando-se o conjunto de avaliações, houve uma correlação entre capacidade aeróbica e a velocidade de onda de pulso de maneira que a maior velocidade de onda de pulso associou-se a menores valores de VO2max.

Conclusão 48

Com a realização do presente trabalho pôde-se concluir que o protocolo de treinamento físico proposto, em pacientes portadores de doença renal crônica, foi eficaz na diminuição da velocidade da onda de pulso e melhora da proteína-C reativa apenas em pacientes em tratamento conservador. E, quando analisados os dados dos pacientes com aumento da capacidade aeróbica, essa variável demonstrou ser associada à evolução do índice de massa ventricular, em pacientes com doença renal crônica em ambos os métodos de tratamento. Outros estudos com número maior de pacientes, preferencialmente multicêntricos precisam ser realizados para a confirmação desses achados.

Referências 50

1. “KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease,” American Journal of Kidney

Diseases, vol. 49, no. 2, supplement 2, pp. S12–S154, 2007,

10.1053/j.ajkd.2006.12.005.

2. C. A. Johnson, A. S. Levey, J. Coresh, A. Levin, J. Lau, and G. Eknoyan, “Clinical practice guidelines for chronic kidney disease in adults: part I. Definition, disease stages, evaluation, treatment, and risk factors,” American Family

Physician, vol. 70, no. 5, pp. 869–876, 2004.

3. KIDNEY DISEASE OUTCOMES QUALITY INITIATIVE (K/DOQI) – Clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis. 2002; 39 (2 Suppl 1): 43-75.

4. Coelho DM, Castro AM, Tavares HA. Efeitos de um programa de exercícios físicos no condicionamento de pacientes em hemodiálise. J Bras Nefrol 2006;28:121-7.

5. Censo SBN 2008 [homepage da internet]. Disponível em: http://www.sbn.org.br/index.php?censos. Acessado em 28/01/2011.

6. Andrade LGM, Gabriel DP, Martin LC, Cruz AP, Balbi AL, Caramori JT, Barreti P. Sobrevida em hemodiálise no hospital das clínicas da faculdade de medicina de Botucatu UNESP: comparação entre a primeira e a segunda metade da década de 90. J BrasNefrol 2005; 27:1-7.

7. Meisinger C, Doring A, Lowel H: Chronic kidney disease and risk of incident myocardial infarction and all cause and cardiovascular disease mortality in middle-aged men and women from the general population. Eur Heart J 2006;27:1245-1250.

8. O'Rourke MF, Yaginuma T, Avolio AP: Physiological and pathophysiological implications of ventricular/vascular coupling. Ann Biomed Eng 1984;12:119- 134.

Referências 51

9. Ritz E, Zeier M, Schneider P, Jones E: Cardiovascular mortality of patients with polycystic kidney disease on dialysis: Is there a lesson to learn? Nephron 1994;66:125-128.

10. Safar ME, Levy BI, Struijker-Boudier H (2003) Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation 107:2864-2869.

11. Safar ME, Blacher J, Pannier B (2002) Central pulse pressure and mortality in end-stage renal disease. Hypertension 39:735-738.

12. Savage MT, Ferro CJ, Pinder SJ et al (2002) Reproducibility of derived central arterial wave forms in patients with chronic renal failure. Clinical Science 103:59-65.

13. Tillin T, Chambers J, Malik I (2007) Measurement of pulse wave velocity: site matters. J Hypertens 25:383-389.

14. Covic A, Goldsmith DJA, Panaghiu L (2000) Analysis of the effect of hemodialysis on peripheral and central arterial pressure waveforms. Kidney Int 57:2634-2643.

15. Ferro CJ, Savage T, Pinder SJ et al (2002) Central aortic pressure augmentation in stable transplant recipients.Kidney Int; 62:166-171.

16. Mitchell GF, Hwang S, Vasan RS et al (2010) Arterial stiffness and cardiovascular events: the Framingham heart study. Circulation 121:505- 511.

17. Devereux RB, Reichek N: Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977;55:613- 618.

18. Edwards NC, Ferro CJ, Townend JN, Steeds RP: Aortic distensibility and arterial-ventricular coupling in early chronic kidney disease: A pattern resembling heart failure with preserved ejection fraction. Heart 2008;94:1038-1043.

Referências 52

19. Piper HM, Kasseckert SA, Schluter KD, Abdallah Y: [pathophysiology of myocardial reperfusion injury]. Dtsch Med Wochenschr 2008;133:586-590. 20. Wang JJ, O´Brien OB, Shrive NV et al (2003) Time-domain representation of

ventricular-arterial coupling as a windkessel and wave system. Am J Physiol Heart Circ Physiol 284:1358-1368

21. M. Temmar, S. Liabeuf, C. Renard et al., “Pulse wave velocity and vascular calcification at different stages of chronic kidney disease,” Journal of

Hypertension, vol. 28, no. 1, pp. 163–169, 2010.

22. T. Shoji, K. Maekawa, M. Emoto et al., “Arterial stiffness predicts cardiovascular death independent of arterial thickness in a cohort of hemodialysis patients,” Atherosclerosis, vol. 210, no. 1, pp. 145–149, 2010 23. Guerin AP, Pannier B, Marchais SJ, London GM: Cardiovascular disease in the

dialysis population: Prognostic significance of arterial disorders. Curr Opin Nephrol Hypertens 2006;15:105-110.

24. Mancia G, De Backer G, Dominiczak A, et al. 2007 guidelines for themanagement of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension(ESH) and of the European Society of Cardiology (ESC).J Hypertens2007;25:1105– 87.

25. Franklin SS, Gustin WT, Wong ND et al (1997) Hemodynamic patterns of age related changes in blood pressure. The Framingham heart study. Circulation 96:308-315.

26. Chantler PD, Lakatta EG, Najjar SS: Arterial-ventricular coupling: Mechanistic insights into cardiovascular performance at rest and during exercise. J Appl Physiol 2008;105:1342-1351.

27. Kass DA: Ventricular arterial stiffening: Integrating the pathophysiology. Hypertension 2005;46:185-193.

Referências 53

28. Laurent S, Cockcroft J, Van Bortel L, et al. European Network for Non- invasive Investigation of Large Arteries. Expert consensus documentation arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27:2588–605.

29. Nichols WW, O’Rourke MF. McDonald’s Blood Flow in Arteries.London: Arnold, 2005.

30. Toprak A, Reddy J, Chen W, Srinivasan S, Berenson G. Relation ofpulse pressure and arterial stiffness to concentric left ventricular hypertrophy in young men (from the Bogalusa Heart Study). Am J Cardiol 2009;103:978–84 31. Watanabe H, Ohtsuka S, Kakihana M, Sugishita Y. Coronarycirculation in dogs with an experimental decrease in aortic compliance. J Am Coll Cardiol 1993;21:1497–506.

32. Ikonomidis I, Lekakis J, Papadopoulos C, et al. Incremental value of pulse wave velocity in the determination of coronary microcirculatorydysfunction in never-treated patients with essential hypertension. Am J Hypertens 2008;21:806 –13.

33. Little WC, Pu M: Left ventricular-arterial coupling. J Am Soc Echocardiogr 2009;22:1246-1248.

34. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'Establishing normal and reference values'. Eur Heart J 2010;31:2338-2350.

35. Wong RC, Dumont CA, Austin BA, Kwon DH, Flamm SD, Thomas JD, Starling RC, Desai MY: Relation of ventricular-vascular coupling to exercise capacity in ischemic cardiomyopathy: A cardiac multi-modality imaging study. Int J Cardiovasc Imaging 2010;26:151-159.

36. B. A. Kingwell, “Nitric oxide-mediated metabolic regulation during exercise: effects of training in health and cardiovascular disease,” The FASEB Journal, vol. 14, no. 12, pp. 1685–1696, 2000.

Referências 54

37. Y. Higashi and M. Yoshizumi, “Exercise and endothelial function: role of endothelium-derived nitric oxide and oxidative stress in healthy subjects and hypertensive patients,” Pharmacology and Therapeutics, vol. 102, no. 1, pp. 87–96, 2004.

38. G. Kojda and R. Hambrecht, “Molecular mechanisms of vascular adaptations to exercise: physical activity as an effective antioxidant therapy?”

Cardiovascular Research, vol. 67, no. 2, pp. 187–197, 2005.

39. Painter P, Ward K, Nelson RD: Self-reported physical activity in patients with end stage renal disease. Nephrol Nurs J 2011;38:139-147; quiz 148

40. Painter P: Determinants of exercise capacity in ckd patients treated with hemodialysis. Adv Chronic kidney Dis 2009;16:437-448.

41. Corra U, Mezzani A, Bosimini E, Giannuzzi P: Prognostic value of time-related changes of cardiopulmonaryexercise testing indices in stable chronic heart failure: apragmatic and operative scheme. Eur J Cardio vasc Prev Rehabil 13:186-192, 2006

42. Kosmadakis GC, Zeferos N. Physical exercise in dyalisis patients. Int J Artific Oragans 2007;30:429-34.

43. Adams G, Valziri ND. Skeletal muscle dysfunction in chronic renal failure: Effect of exercise. Am J Physiol Renal Physiol 2006;290:783-91.

44. Sakkas GK, Sargeant AJ, Mercer TH et al (2003) Changes in muscle morphology in dialysis patients after 6 months of aerobic exercise training. Nephrol Dial Transplant 18:1854-1861.

45. Ham ECH, Kooman JP, Schols AMWJ (2007) The functional, metabolic, and anabolic responses to exercise training in renal transplant and hemodialysis patients. Transplantation 83:1059-1068.

46. Sietsema KE, Amato A, Adler SG, Brass EP. Exercise capacity as a predictor of survival among ambulatory patients with end-stage renal disease. Kidney

Referências 55

47. Mustata S, Chan C, Lai V et al (2004) Impact of an exercise program on arterial stiffness and insulin resistance in hemodialysis patients. J Am Soc Nephrol 15:2713-2718.

48. Toussaint ND, Polkinghorne KR, Kerr PG (2008). Impact of intradialytic exercise on arterial compliance and B-type natriuretic peptide levels in hemodialysis patients. Hemodialysis International 212: 254-263

49. Nakamura M, Yamabe H, Kitajima M, Kudo U, Urushizaka M, Tomisawa T, et

al. Physical Activity levels of patients undergoing hemodialysis. Dialysis

Transplant. 2010;39 (9): 386-90.

50. Mustata S, Groeneveld S, Davidson W, Ford G, Kiland K, Manns B. Effects of exercise training on physical impairment, arterial stiffness and health- related quality of life in patients with chronic kidney disease: a pilot study. Int Urol Nephrol. 2011; 43: 1133-41

51. Kouidi E: Central and peripheral adaptations to physicaltraining in patients withend-stage renal disease. Sports Med 31:651-665, 2001

52. Painter P: Exercise in chronic disease: Physiologicalresearch needed. Exerc Sport Sci Rev 36:83-90, 2008

53. Deligiannis A: Exercise rehabilitation and skeletalmuscle benefits in hemodialysis patients. Clin Nephrol 61: S46-S50, 2004 (suppl1)

54. Painter P. Physical functioning in end-stage renal disease patients: Update 2005. Hemodial Int. 2005; 9: 218–35.

55. Hiraki K, Yasuda T, Hotta C et al. Decreased physical function in pre-dialysis patients with chronic kidney disease. Clin Exp Nephrol 2013; 17 (2): 1–7. 56. Roshanravan B, Robinson-Cohen C, Patel KV et al. Association between

Physical performance and all-cause mortality in CKD. J Am Soc. Nephrol 2013; 24: 822–30.

Referências 56

57. Konstantinidou E, Koukouvou G, Kouidi E, Deligiannis A, Tourkantonis A: Exercise training in patientswith end-stage renal disease on hemodialysis: Comparisonof three rehabilitation programs. J Rehabil Med34:40-45, 2002 58. Cheema BS, Singh MA: Exercise training in patientsreceiving maintenance

hemodialysis:Asystematic review ofclinical trials. .Am J Nephrol 25:352- 364,2005

59. Johansen KL: Exercise in the end-stage renal diseasepopulation. J Am Soc Nephrol 18:1845-1854, 2007

60. Barros Neto TL, Tebexreni AS, Tambeiro VL. Aplicações práticas da ergoespirometria no atleta. Rev Soc Cardiol. 2001; 11(3):695-705.

61. Heiwe S, Jacobson SH. Exercise training for adults with chronic kidney disease. Cochrane Database (Syst Rev. 2011; 5(10): CD003236.

62. Bruce RA, Kusumi F, Hosner D (1973) Maximal oxygen intake and normographic assessment of functional aerobic impairment in cardiovascular disease. American Heart Journal 85: 546-562.

63. Smith AC, Burton JO. Exercise in kidney disease and diabetes: Time for action. J. Ren. Care 2012; 38 (Suppl 1): 52–8.

64. KDIGO. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Int. Soc. Nephrol. 2013; 3: 1–163. 65. K/DOQI. K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in

Dialysis Patients.Am. J. Kidney Dis. 2005; 45 (4 Suppl 3): S1–153.

66. Cheema BSB, O´Sullivan AJ, Chan M, et al. Progressive resistance training during hemodialysis: rationale ans method of a randomized-controlled trial. Hemodialysis Onternational 2006;10:303-10.

67. Cheema B, Abas H, Smith B, ET AL. Progressive exercise for anabolism in kidney disease (PEAK): a randomized, controlled trail of resistance trianing during hemodialysis. J Am Soc Nephrol 2007;18:1594-1601.

Referências 57

68. Touboul PJ, Hennerici MG, Mears S (2007). Mannheim carotid intima- mediathickness consensus (2004-2006): An Update on Behalf of the Advisory Board ofthe 3rd and 4th Watching the Risk Symposium 13th and 15th _{European Stroke Conferences, Mannheim, Germany, 2004, and Brussels,}

Belgium, 2006. Cerebrovasc Dis 23:75-80.

69. Lang RM, Badano LP, Mor-Avi P, et al. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2015;28:1-39.

70. Sarnak MJ, Levey AS. Cardiovascular disease and chronic renal disease: a new paradigma. Am J Kidney Dis 2000;35:117-31.

71. Briet M, Pierre B, Laurent S, London GM. Arterial stiffness and pulse pressure in CKD and ESRD. Kidney Int 2012;82(4):388-400.

72. Takashima N, Turin TC, Matsui K, et al. The relationship of brachial-ankle pulse wave velocity to future cardiovascular disease events in general Japanese population: the Takashima study. J Hum Hypertens 2014;28:323-7. 73. Ohishi M, Tatara Y, Ito N, et al. The combination of chronic kidney disease

and increased arterial stiffness is a predictor of stroke and cardiovascular disease in hypertensive patients. Hypertens Res 2011;34:1209-15.

74. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Eng J Med 2002;346(11):793-801.

75. O´Hare AM, Tawney K, Bacchetti P, Johansen KL. Decreased survival among sedentary patient undergoing dialysis: results from Dialysis morbity and mortality study wave 2. Am J Kidney Dis 2003;41(2):447-54.

76. Rauramaa R, Halonen P, Vaisanem SB, et al. Effects of aerobic physical exercise on inflammation and atherosclerosis in men: the DNASCO Study: a six years randomized, controlled trial. Ann Intern Med 2004;140(12)1007- 14.

Referências 58

77. Boyce ML, Robergs RA, Avasthi OS, et al. Exercise training by individuals with predialysis renal failure: Cardiorespiratory endurance, hypertension, and renal failure. Am J Kidney Dis 1997;30:180-92.

78. Headley S, Germain M, Milch C, et al. Exercise training improves HR responses and VO2peak in predialysis kidney patients. Med Science Sports Exerc

2012;44:2392-9.

79. Kosmadakis GC, John SG, Clapp EL, et al. Benefits of regular walking exercise in advanced pre-dialysis chronic kidney disease. Nephrol Dial Transplnat 2012;27:997-1004.

80. Bohm J, Monteiro MB, Thomé FS. Efeitos do exercício aeróbico durante a hemodiálise em pacientes com doença renal crônica: uma revisão da literatura. J Bras Nefrol 2012;34(2):189-94.

81. Greenwood SA, Koufaki P, Mercer TH, et al. Effect of exercise training on estimated GFR, vascular health, and cardiorespiratory fitness in patients with CKD: a pilot randomized controlled trial. Am J Kidney Dis 2015;65(3):425-34.

82. Van Craenenbroeck AH, Van Craenenbroeck EM, Van Ackeren K, et al. Effect of moderate aerobic exercise training on endothelial function and arterial stiffness in CKD stages 3-4: A randomized controlled trial. Am J Kidney Dis 2015;66(2):285-96.

83. Headley S, Germain, Wood R elt al. Short term aerobic exercise and vascular function in CKD stage 3: a randomized controlled trial. Am J Kid Dis 2014;64(2):222-9.

84. Kato A, Takita T, Maruyama Y, Kumagai H, Hishida A. Impact of carotid atherosclerosis on long-term mortality in chronic hemodialysis patients. Kidney Int 2003;64; 1472-9.

85. Benedetto FA, Mallaci F, Tripepi G, Zoccali C. Prognostic value of ultrasonographic measurement of carotid intima media thickness in dialysis patients. J Am Soc Nephrol 2001;12: 2458-64.

Referências 59

86. Shoji T, Maekawa K, Emoto M, et AL. Arterial stiffness predicts cardiovascular death independent of arterial thickness in a cohort of hemodialysis patients. Atherosclerosis 2010;210:145-149.

87. Chen KC, Hsieh CL, Peng CC, Peng RY. Exercise rescue chronic kidney disease by attenuating cardiac hypertrophy through the cardiotrophin-1->LIFR/gp 130 ->JAK/STAT3 pathway. Eur J Prev Cardiol 2014;21(4):507-20.

88. Silva LR, Silva KAS Rampaso RR, et al. Exercise Attenuates Renal Dysfunction with Preservation of Myocardial Function in Chronic Kidney Disease. PLOS ONE 2013;8(2):553-63.

89. Meuwese CI, Snaedal S, Halbesma N, et AL. Trimestral variations of C- reactive protein, interleukin-6 and tumor necrosis factor-α are similarly associated with survival in haemodialysis patients. Nephrology Dialysis Transplantation 2011;26(4):1313-8.

90. Ortega O, Rodriguez I Gallar P, ET AL. Significance of high C-reative protein levels in pré-dualyisis patients. Nephrology Dialysis Transplantation 2002;17(6):1005-9.

91. Shiraishi FG, Belik FS, Silva VRO, et al. Inflammation, diabetes and chronic kidney disease: role of aerobic capacity. Experimental Diabetes Research , volume 2012, Article ID 750286, 6 pages.

92. Painter P, Moore G, Carlson L, Paul S, Myll J, Phillips W, et al. Effects of exercise training plus normalization of hematocrit on exercise capacity and health-related quality of life. Am J Kidney Dis. 2002;39(2):257-65.

93. DePaul V, Moreland J, Eager T, Clase CM. The effectiveness of aerobic and muscle strength training in patients receiving hemodialysis and EPO: a randomized controlled trial. Am J Kidney Dis. 2002;40(6):1219-29.

94. Kopple JD, Massry SG. Cuidados nutricionais das doenças renais. Rio de Janeiro: Guanabara Koogan, 2006.

Referências 60

95. Chemma BS, Chan D, Fahey P, Atalantis E. Effect of progressive resistance training on measures of skeletal muscle hyperthrophy, muscular strength and health-related quality of life in patients with chronic kidney disease: a sistematic review and meta-analysis. Sports Med 2014;44(8):1125-38.

96. Watson EL, Greening NJ, Viana JL, et al. Progressive resistance training in CKD: A feasibility study. Am J Kidney Dis 2014. doi:10.1053/j.ajkd.2014.10.019.

97. Bhadauria D, Agarwal N. Uremic Myopathy. Nephrology 2012;1:279-83. 98. Bronas UG. Exercise training and reduction of cardiovascular disease risk

factors in patients with chronic kidney disease. Adv Chronic Kidney Dis 2009;16(6):449-58.

99. Hambrecht R, Adams V, Erbs S, et al. Regular physical activity improves endotelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase. Circulation 2003;107:3152-8.

100. Bonapace S, Rossi A, Cicoira M et al. Aortic distensibility independently affects exercise tolerance in patients with dilated cardiomyopathy. Circulation 2003;107:1603-1608.

101. Binder J, Bailey KR, Seward JB et al (2006) Aortic augmentation index is inversely associated with cardiorespiratory fitness in men without know coronary heart disease. Am J Hypertens 2006:19: 1019-1024.

Anexos 62

Anexos 63

Anexos 64

Anexos 66

Anexos 67